Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Delayed membranous cranial ossification is a rare, genetic primary bone dysplasia characterized by absent ossification of calvarial bones at birth and characteristic facial dysmorphisms (frontal bossing, hypertelorism, downward-slanting palpebral fissures, proptosis, flat nasal bridge, low-set ears, midface retrusion). Patients present a soft skull at birth which, over time, progressively ossifies and in adulthood typically results in a deformed skull (with brachycephaly and prominent occiput). No other skeletal abnormalities are associated and patients have normal cognitive and motor development.
Features include: Downslanted palpebral fissures, Hypertelorism, High forehead, and Frontal bossing and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Depressed nasal bridge |
Biomarker and diagnostic research for delayed membranous cranial ossification has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for delayed membranous cranial ossification.
100 publications have been identified in PubMed for delayed membranous cranial ossification. Research spans Basic Science / Preclinical (24%), Epidemiology / Natural History (22%), and Clinical Trial Publication (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 23 | 24% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
21 |
22% |
Clinical study results | 15 | 16% |
Research summaries | 14 | 15% |
Patient case studies | 14 | 15% |
Testing and diagnosis research | 4 | 4% |
New treatment approaches | 4 | 4% |
Other research | 1 | 1% |
Abed M (2026). [PMID: 42159013](https://pubmed.ncbi.nlm.nih.gov/42159013/). *Crit Pathw Cardiol*. [Epidemiology / Natural History]
Justiz Vaillant AA (2026). [PMID: 29939682](https://pubmed.ncbi.nlm.nih.gov/29939682/). *Unknown Journal*. [Clinical Trial Publication]
Parks DH (2026). [PMID: 41809988](https://pubmed.ncbi.nlm.nih.gov/41809988/). *Front Cell Infect Microbiol*. [Diagnostic / Biomarker]
Chen Z (2026). [PMID: 41786942](https://pubmed.ncbi.nlm.nih.gov/41786942/). *Eur Arch Otorhinolaryngol*. [Case Report / Case Series]
Endara-Mina J (2026). [PMID: 41810237](https://pubmed.ncbi.nlm.nih.gov/41810237/). *Front Med (Lausanne)*. [Case Report / Case Series]
Bakhos C (2026). [PMID: 41767010](https://pubmed.ncbi.nlm.nih.gov/41767010/). *Front Neurol*. [Basic Science / Preclinical]
Mileva N (2026). [PMID: 41646880](https://pubmed.ncbi.nlm.nih.gov/41646880/). *Eur Heart J Imaging Methods Pract*. [Epidemiology / Natural History]
Zeuzem N (2026). [PMID: 41851261](https://pubmed.ncbi.nlm.nih.gov/41851261/). *Eur J Hum Genet*. [Diagnostic / Biomarker]
Suárez-Cuenca JA (2026). [PMID: 41745110](https://pubmed.ncbi.nlm.nih.gov/41745110/). *Diseases*. [Epidemiology / Natural History]
Saez-Berlanga A (2026). [PMID: 41771463](https://pubmed.ncbi.nlm.nih.gov/41771463/). *Arch Phys Med Rehabil*. [Review / Meta-Analysis]